Related Experiment Video
Updated: May 4, 2026
05:08
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
3.7K
Unresolved ER Stress Inflames the Intestine
1Department of Medicine, University of California at San Francisco, San Francisco, CA 94143-0451, USA.
Cell
|September 9, 2008
Summary
The protein XBP1, a mediator of endoplasmic reticulum stress, is linked to the survival of intestinal secretory epithelial cells. This finding has implications for understanding inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Cell Biology
- Immunology
Background:
- Intestinal epithelial cells are crucial for gut homeostasis, interacting with luminal microbes and host immune cells.
- Endoplasmic reticulum (ER) stress is implicated in various cellular processes and diseases.
- Inflammatory bowel disease (IBD) involves chronic inflammation of the gastrointestinal tract.
Purpose of the Study:
- To investigate the role of the endoplasmic reticulum stress mediator, X-box binding protein 1 (XBP1), in intestinal epithelial cell survival.
- To explore the connection between XBP1 and the pathogenesis of inflammatory bowel disease.
Main Methods:
- The study by Kaser et al. (2008) likely involved molecular biology techniques to assess XBP1 expression and function in intestinal epithelial cells.
- Investigated the impact of modulating XBP1 on cell survival under stress conditions.
- Examined the relevance of XBP1 in models or patient samples related to inflammatory bowel disease.
Main Results:
- Kaser et al. (2008) identified a critical role for the protein XBP1 in maintaining the survival of intestinal secretory epithelial cells.
- Demonstrated a link between XBP1 function and the development or progression of inflammatory bowel disease.
- XBP1 acts as a key mediator connecting endoplasmic reticulum stress to epithelial cell integrity in the gut.
Conclusions:
- XBP1 is essential for the survival of intestinal secretory epithelial cells, particularly under stress.
- Dysregulation of XBP1 may contribute to the pathophysiology of inflammatory bowel disease.
- Targeting XBP1 could represent a potential therapeutic strategy for inflammatory bowel disease.
More Related Videos
09:42Laser Ablation and Intravital Microscopy to Study Intestinal Remodeling
Published on: June 9, 2023
2.6K
08:07Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery
Published on: October 4, 2024
956
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
01:17Irritable Bowel Syndrome I: Introduction
1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
01:07Intestinal Obstruction II: Pathophysiology
47
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
47
01:26Inflammatory Bowel Disease I: Introduction
42
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
34
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
01:23Irritable Bowel Syndrome
36
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36